ScholarIQanswers from OpenAlex
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy
PaperCitations, authors & open-access status
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy have?
ScholarIQcitation count
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy has 58 citations in the OpenAlex counts ScholarIQ stores.
When was Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy published?
ScholarIQyear
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy has 2017 year in the ScholarIQ index.
What is the open-access status of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy?
ScholarIQoa status
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy has bronze oa status in the ScholarIQ index.
What is the DOI of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy?
ScholarIQdoi
The DOI for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy is on the source record.
What is the PMID of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy?
ScholarIQpmid
The PMID for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy is on the source record.
What is the OpenAlex record for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy?
ScholarIQopenalex
The OpenAlex for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy is on the source record.